Fate Therapeutics, Inc. (FATE)

USD 1.69

(-10.37%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 506.21 Million 705.56 Million 921.45 Million 622.45 Million 302.27 Million 213.03 Million
Total Current Assets 331.54 Million 502.07 Million 633.41 Million 494.32 Million 227.08 Million 205.19 Million
Cash And Short Term Investments 315.17 Million 436.22 Million 615.91 Million 482.91 Million 221.42 Million 201 Million
Cash and Cash Equivalents 41.87 Million 61.33 Million 133.58 Million 167.34 Million 99.81 Million 190.51 Million
Short Term Investments 273.3 Million 374.89 Million 482.32 Million 315.56 Million 121.61 Million 10.49 Million
Net Receivables 2.72 Million 38.48 Million 8.67 Million 5.51 Million 1.33 Million 500 Thousand
Inventory - 1.00 - 1.00 - 1.00
Other Current Assets 13.63 Million 27.36 Million 8.82 Million 5.89 Million 4.32 Million 3.68 Million
Total Non-Current Assets 174.67 Million 203.48 Million 288.04 Million 128.13 Million 75.18 Million 7.83 Million
Net PPE 158.51 Million 66.06 Million 70.72 Million 67.08 Million 22.75 Million 5.12 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 16.15 Million 4.94 Million 100.66 Million 28.73 Million 39.44 Million 2.18 Million
Tax Assets - - - - - -
Other Non Current Assets 8999.00 132.47 Million 116.65 Million 32.31 Million 12.99 Million 526 Thousand
Other Assets 1.00 - - - - -
Total Liabilities 137.8 Million 221.62 Million 242.61 Million 238.01 Million 57.51 Million 52.56 Million
Total Current Liabilities 39.09 Million 114.05 Million 81.28 Million 85.56 Million 27.8 Million 27.26 Million
Account Payables 4.71 Million 8.26 Million 8.61 Million 6.28 Million 5.82 Million 4.2 Million
Tax Payables - - - - - -
Short Term Debt 6.17 Million 5.62 Million 5.57 Million 3.35 Million 1.69 Million 2.43 Million
Deferred Revenue 685 Thousand 42.22 Million 21.48 Million 21.14 Million 2.78 Million 7.58 Million
Other Current Liabilities 27.51 Million 57.93 Million 45.61 Million 54.78 Million 17.5 Million 13.03 Million
Total Non Current Liabilities 98.7 Million 107.57 Million 161.33 Million 152.44 Million 29.71 Million 25.3 Million
Long-Term Debt 97.36 Million 103.71 Million 109.24 Million 93.94 Million 25.23 Million 12.44 Million
Deferred Revenue Non Current - - 27.12 Million 46.02 Million 3.77 Million 7.5 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.34 Million 3.86 Million 800 Thousand 800 Thousand 702 Thousand 5.35 Million
Other Liabilities - - - - - -
Total Equity 368.41 Million 483.93 Million 678.83 Million 384.44 Million 244.75 Million 160.46 Million
Stock Holders Equity 368.41 Million 483.93 Million 678.83 Million 384.44 Million 244.75 Million 160.46 Million
Common Stock 99 Thousand 97 Thousand 96 Thousand 88 Thousand 76 Thousand 65 Thousand
Retained Earnings -1.21 Billion -1.05 Billion -769.08 Million -556.93 Million -383.54 Million -285.39 Million
Accumulated other comprehensive income 15 Thousand -1.85 Million -762 Thousand 70 Thousand 22 Thousand -2000.00
Common Stock Equity 368.41 Million 483.93 Million 678.83 Million 384.44 Million 244.75 Million 160.46 Million
Capital Lease Obligation 97.36 Million 109.33 Million 114.81 Million 97.29 Million 26.92 Million -
Total Investments 289.46 Million 379.83 Million 582.99 Million 315.56 Million 161.05 Million 10.49 Million
Total Debt 103.53 Million 109.33 Million 114.81 Million 97.29 Million 26.92 Million 14.88 Million
Net Debt 61.66 Million 48 Million -18.76 Million -70.04 Million -72.88 Million -175.63 Million

Balance Sheet Charts